China Pharma Holdings (CPHI) Receivables - Net (2016 - 2025)
Historic Receivables - Net for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $294514.0.
- China Pharma Holdings' Receivables - Net fell 9793.6% to $294514.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $294514.0, marking a year-over-year decrease of 9793.6%. This contributed to the annual value of $13.8 million for FY2024, which is 329.73% down from last year.
- According to the latest figures from Q3 2025, China Pharma Holdings' Receivables - Net is $294514.0, which was down 9793.6% from $13.9 million recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Receivables - Net ranged from a high of $14.3 million in Q4 2023 and a low of $275244.0 during Q2 2023
- For the 5-year period, China Pharma Holdings' Receivables - Net averaged around $5.4 million, with its median value being $545094.0 (2021).
- Per our database at Business Quant, China Pharma Holdings' Receivables - Net surged by 497220.03% in 2024 and then plummeted by 9793.6% in 2025.
- Over the past 5 years, China Pharma Holdings' Receivables - Net (Quarter) stood at $714475.0 in 2021, then tumbled by 41.0% to $421531.0 in 2022, then skyrocketed by 3290.15% to $14.3 million in 2023, then fell by 3.3% to $13.8 million in 2024, then crashed by 97.87% to $294514.0 in 2025.
- Its last three reported values are $294514.0 in Q3 2025, $13.9 million for Q2 2025, and $13.9 million during Q1 2025.